Pathologic Complete Response to Intralesional Interleukin-2 Therapy Associated with Improved Survival in Melanoma Patients with In-Transit Disease - Concepedia

Concepedia

Publication | Closed Access

Pathologic Complete Response to Intralesional Interleukin-2 Therapy Associated with Improved Survival in Melanoma Patients with In-Transit Disease

19

Citations

30

References

2014

Year

Saima Hassan, Teresa M. Petrella, Tong Zhang, Suzanne Kamel‐Reid, Francesco Nordio, Andrea Baccarelli, Shachar Sade, Karen Naert, Ayman Al Habeeb, Danny Ghazarian,

Annals of Surgical Oncology

InflammationCytokineCancer ImmunosurveillanceImproved SurvivalPathologic Complete ResponseMelanomaImmunologyTumor ImmunityPathologyImmune SurveillanceAutoimmunityImmune Checkpoint InhibitorMelanoma PatientsImmunotherapyMedicineTumor Microenvironment

References

	Year	Citations

Page 1

Page 1